GKIM
EBS icon

GW&K Investment Management’s Emergent Biosolutions EBS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-45
Closed -$2K 819
2021
Q4
$2K Sell
45
-499,773
-100% -$22.2M ﹤0.01% 384
2021
Q3
$25M Sell
499,818
-4,819
-1% -$241K 0.22% 177
2021
Q2
$31.8M Buy
504,637
+4,194
+0.8% +$264K 0.28% 159
2021
Q1
$46.5M Sell
500,443
-128,738
-20% -$12M 0.43% 84
2020
Q4
$56.4M Buy
629,181
+166,325
+36% +$14.9M 0.59% 39
2020
Q3
$47.8M Buy
462,856
+101,583
+28% +$10.5M 0.63% 37
2020
Q2
$28.6M Buy
361,273
+357,519
+9,524% +$28.3M 0.4% 102
2020
Q1
$217K Sell
3,754
-2,570
-41% -$149K ﹤0.01% 298
2019
Q4
$341K Sell
6,324
-380
-6% -$20.5K ﹤0.01% 311
2019
Q3
$350K Buy
6,704
+10
+0.1% +$522 ﹤0.01% 303
2019
Q2
$323K Sell
6,694
-15
-0.2% -$724 ﹤0.01% 315
2019
Q1
$339K Buy
6,709
+9
+0.1% +$455 0.01% 281
2018
Q4
$397K Buy
6,700
+48
+0.7% +$2.84K 0.01% 246
2018
Q3
$438K Buy
6,652
+132
+2% +$8.69K 0.01% 248
2018
Q2
$329K Buy
6,520
+455
+8% +$23K 0.01% 271
2018
Q1
$319K Buy
6,065
+1,755
+41% +$92.3K 0.01% 259
2017
Q4
$200K Buy
+4,310
New +$200K ﹤0.01% 262
2016
Q3
Sell
-112,307
Closed -$3.16M 222
2016
Q2
$3.16M Buy
112,307
+12,274
+12% +$345K 0.07% 193
2016
Q1
$3.64M Buy
100,033
+46,108
+86% +$1.68M 0.08% 184
2015
Q4
$2.16M Sell
53,925
-420
-0.8% -$16.8K 0.05% 186
2015
Q3
$1.55M Buy
54,345
+885
+2% +$25.2K 0.04% 189
2015
Q2
$1.76M Sell
53,460
-1,665
-3% -$54.9K 0.04% 194
2015
Q1
$1.59M Buy
55,125
+14,430
+35% +$415K 0.04% 198
2014
Q4
$1.11M Buy
40,695
+5,590
+16% +$152K 0.03% 202
2014
Q3
$748K Buy
35,105
+7,980
+29% +$170K 0.02% 210
2014
Q2
$609K Buy
27,125
+10,770
+66% +$242K 0.02% 212
2014
Q1
$413K Buy
16,355
+2,005
+14% +$50.6K 0.01% 207
2013
Q4
$330K Buy
14,350
+2,275
+19% +$52.3K 0.01% 211
2013
Q3
$230K Buy
12,075
+1,315
+12% +$25K 0.01% 214
2013
Q2
$155K Buy
+10,760
New +$155K 0.01% 216